Repurposing Chlorpromazine in the Treatment of Glioblastoma

Clinical trial NCT04224441 · UNKNOWN

Trial details

NCT number: NCT04224441
Sponsor: Marco G Paggi, MD, PhD
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme MGMT-Unmethylated Glioblastoma

Start date: 2019-12-15
Primary completion: 2022-06-15
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.